A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActive) for COVID-19 Patients

DOI record: { "DOI": "10.1155/2021/8447545", "ISSN": [ "1741-4288", "1741-427X" ], "URL": "http://dx.doi.org/10.1155/2021/8447545", "abstract": "<jats:p>Background. SARS-CoV-2 has emerged as a global threat due to its infectivity and rapid transmission. We evaluated the safety and efficacy of herbal and mineral formulation (ImmuActive) as an adjunct therapy in COVID-19 patients. Methods. A randomized, double-blind, placebo-controlled study was conducted in 100 COVID-19 patients in three centers in Southern India, and 92 subjects completed the study. Subjects were followed up until they were discharged from the hospital or for a maximum of 28 days, whichever was earlier. The primary outcome parameters were the mean change and time required to change the ordinal scale of disease severity by one unit. The secondary outcomes were the time required to turn RT-PCR negative or get discharged from the hospital, change in modified Jackson’s Symptom Severity score, and COVID-19 quality of life questionnaire. Results. The ordinal scale at the end of the study was significantly lower in COVID-19 patients supplemented with ImmuActive (0.57) than placebo (1.0), with a <jats:inline-formula>\n <math xmlns=\"http://www.w3.org/1998/Math/MathML\" id=\"M1\">\n <mi>p</mi>\n </math>\n </jats:inline-formula> value of 0.0043. The ordinal scale decreased by one unit within 2.35 days in ImmuActive-supplemented patients, while it took 3.36 days in placebo-supplemented patients. Days of hospitalization and time required to turn RT-PCR negative were comparatively lower in the ImmuActive arm than the placebo arm. Change in modified Jackson’s Symptom Severity Score and COVID-19 QOL were significant from screening to the end of the study in both ImmuActive and placebo arms. There were no adverse events observed during the study period. Conclusion. The study results suggest that ImmuActive could be a beneficial and safe adjunct treatment for effectively managing COVID-19 infection symptoms.</jats:p>", "alternative-id": [ "8447545", "8447545" ], "author": [ { "ORCID": "http://orcid.org/0000-0002-1690-7470", "affiliation": [ { "name": "Sami-Sabinsa Group Limited, 19/1, 19/2, I Main, II Phase, Peenya Industrial Area, Bangalore, Karnataka 560 058, India" }, { "name": "Sabinsa Corporation, 20 Lake Drive, East Windsor, Piscataway, NJ 08520, USA" } ], "authenticated-orcid": true, "family": "Majeed", "given": "Muhammed", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0001-9470-4110", "affiliation": [ { "name": "Sabinsa Corporation, 20 Lake Drive, East Windsor, Piscataway, NJ 08520, USA" } ], "authenticated-orcid": true, "family": "Nagabhushanam", "given": "Kalyanam", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-7983-9153", "affiliation": [ { "name": "Sami-Sabinsa Group Limited, 19/1, 19/2, I Main, II Phase, Peenya Industrial Area, Bangalore, Karnataka 560 058, India" } ], "authenticated-orcid": true, "family": "Shah", "given": "Kalpesh", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-2928-1726", "affiliation": [ { "name": "Sami-Sabinsa Group Limited, 19/1, 19/2, I Main, II Phase, Peenya Industrial Area, Bangalore, Karnataka 560 058, India" } ], "authenticated-orcid": true, "family": "Mundkur", "given": "Lakshmi", "sequence": "additional" } ], "container-title": "Evidence-Based Complementary and Alternative Medicine", "container-title-short": "Evidence-Based Complementary and Alternative Medicine", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 10, 11 ] ], "date-time": "2021-10-11T17:41:12Z", "timestamp": 1633974072000 }, "deposited": { "date-parts": [ [ 2021, 10, 11 ] ], "date-time": "2021-10-11T17:41:33Z", "timestamp": 1633974093000 }, "editor": [ { "affiliation": [], "family": "Hu", "given": "Changmin", "sequence": "additional" } ], "indexed": { "date-parts": [ [ 2024, 4, 8 ] ], "date-time": "2024-04-08T23:14:29Z", "timestamp": 1712618069858 }, "is-referenced-by-count": 8, "issued": { "date-parts": [ [ 2021, 10, 11 ] ] }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "unspecified", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 10, 11 ] ], "date-time": "2021-10-11T00:00:00Z", "timestamp": 1633910400000 } } ], "link": [ { "URL": "http://downloads.hindawi.com/journals/ecam/2021/8447545.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://downloads.hindawi.com/journals/ecam/2021/8447545.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://downloads.hindawi.com/journals/ecam/2021/8447545.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "98", "original-title": [], "page": "1-9", "prefix": "10.1155", "published": { "date-parts": [ [ 2021, 10, 11 ] ] }, "published-print": { "date-parts": [ [ 2021, 10, 11 ] ] }, "publisher": "Hindawi Limited", "reference": [ { "DOI": "10.26355/eurrev_202004_20871", "doi-asserted-by": "publisher", "key": "1" }, { "article-title": "Coronavirus disease 2019 (COVID-19)–symptoms", "author": "Center for Disease Control and Prevention", "key": "2" }, { "DOI": "10.1017/dmp.2020.149", "doi-asserted-by": "publisher", "key": "3" }, { "DOI": "10.1038/s41423-020-0372-4", "doi-asserted-by": "publisher", "key": "4" }, { "DOI": "10.1016/s1473-3099(20)30243-7", "doi-asserted-by": "publisher", "key": "5" }, { "article-title": "Existing drugs as treatment options for COVID-19: a brief survey of some recent results", "author": "S. Majedi", "first-page": "2", "issue": "1", "journal-title": "Journal of Chemistry Letters", "key": "6", "volume": "1", "year": "2020" }, { "author": "WHO", "key": "7", "volume-title": "WHO Lists Two Additional COVID-19 Vaccines for Emergency Use and COVAX Roll-Out", "year": "2021" }, { "DOI": "10.1038/s41591-021-01230-y", "doi-asserted-by": "publisher", "key": "8" }, { "DOI": "10.1037/e623942009-001", "doi-asserted-by": "publisher", "key": "9" }, { "DOI": "10.1186/1472-6882-14-167", "doi-asserted-by": "publisher", "key": "10" }, { "DOI": "10.1016/j.ctim.2019.08.017", "doi-asserted-by": "publisher", "key": "11" }, { "DOI": "10.1155/2011/983792", "doi-asserted-by": "publisher", "key": "12" }, { "article-title": "Inclusion of a CAM therapy (chiropractic care) for the management of musculoskeletal pain in an integrative, inner city, hospital-based primary care setting", "author": "D. Kopansky-Giles", "first-page": "61", "issue": "1", "journal-title": "Journal of Alternative Medicine Research", "key": "13", "volume": "2", "year": "2010" }, { "DOI": "10.1515/jcim-2018-0088", "doi-asserted-by": "publisher", "key": "14" }, { "DOI": "10.1089/acm.2006.12.805", "doi-asserted-by": "publisher", "key": "15" }, { "article-title": "Antihyperlipidemic effect of seeds of jamun (eugenia jambolana) in subjects of intermediate hyperglycemia: a pilot study", "author": "P. Shagufta", "issue": "4", "journal-title": "Traditional and Integrative Medicine", "key": "16", "volume": "5", "year": "2020" }, { "DOI": "10.3389/fmed.2020.587749", "doi-asserted-by": "publisher", "key": "17" }, { "DOI": "10.1016/j.jiph.2020.07.001", "doi-asserted-by": "publisher", "key": "18" }, { "DOI": "10.1016/S1875-5364(20)30022-4", "article-title": "Traditional Chinese Medicine: an effective treatment for 2019 novel coronavirus pneumonia (NCP)", "author": "D. Hong-Zhi", "doi-asserted-by": "crossref", "first-page": "206", "issue": "3", "journal-title": "Chinese Journal of Natural Medicines", "key": "19", "volume": "18", "year": "2020" }, { "DOI": "10.1371/journal.pone.0256429", "doi-asserted-by": "publisher", "key": "20" }, { "DOI": "10.3389/fphar.2020.01189", "doi-asserted-by": "publisher", "key": "21" }, { "DOI": "10.1002/ptr.6738", "doi-asserted-by": "publisher", "key": "22" }, { "DOI": "10.1007/s13337-020-00598-8", "doi-asserted-by": "publisher", "key": "23" }, { "DOI": "10.1016/j.ejphar.2020.173551", "doi-asserted-by": "publisher", "key": "24" }, { "DOI": "10.3389/fcell.2020.00479", "doi-asserted-by": "publisher", "key": "25" }, { "article-title": "Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy", "author": "J. T. Coon", "first-page": "293", "issue": "4", "journal-title": "Planta Medica", "key": "26", "volume": "70", "year": "2005" }, { "article-title": "Andrographis paniculata: a review of pharmacological activities and clinical effects", "author": "S. Akbar", "first-page": "66", "issue": "1", "journal-title": "Alternative Medicine Review: A Journal of Clinical Therapeutic", "key": "27", "volume": "16", "year": "2011" }, { "DOI": "10.1042/bj3380107", "article-title": "Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters", "author": "A. Basak", "doi-asserted-by": "crossref", "first-page": "107", "issue": "Pt 1", "journal-title": "Biochemical Journal", "key": "28", "volume": "338", "year": "1999" }, { "DOI": "10.3390/nu9060624", "doi-asserted-by": "publisher", "key": "29" }, { "article-title": "Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach", "author": "S. K. Enmozhi", "first-page": "1", "issue": "9", "journal-title": "Journal of Biomolecular Structure and Dynamics", "key": "30", "volume": "39", "year": "2021" }, { "DOI": "10.1016/j.bbrc.2020.08.086", "doi-asserted-by": "publisher", "key": "31" }, { "DOI": "10.4149/av_2020_309", "doi-asserted-by": "publisher", "key": "32" }, { "DOI": "10.1002/ptr.6916", "doi-asserted-by": "publisher", "key": "33" }, { "DOI": "10.1016/s0140-6736(11)61452-9", "doi-asserted-by": "publisher", "key": "34" }, { "DOI": "10.3390/nu11092101", "doi-asserted-by": "publisher", "key": "35" }, { "DOI": "10.1016/j.mehy.2020.109878", "doi-asserted-by": "publisher", "key": "36" }, { "DOI": "10.3390/nu9060624", "doi-asserted-by": "publisher", "key": "37" }, { "DOI": "10.3892/ijmm.2020.4790", "doi-asserted-by": "publisher", "key": "38" }, { "DOI": "10.1016/j.mjafi.2019.12.005", "doi-asserted-by": "publisher", "key": "39" }, { "DOI": "10.3389/fimmu.2020.01712", "doi-asserted-by": "publisher", "key": "40" }, { "DOI": "10.1080/07391102.2020.1847688", "doi-asserted-by": "publisher", "key": "41" }, { "author": "WHO", "key": "42", "volume-title": "R&D Blueprint Novel Coronavirus COVID-19 Therapeutic Trial Synopsis", "year": "2021" }, { "DOI": "10.1371/journal.ppat.1004134", "doi-asserted-by": "publisher", "key": "43" }, { "DOI": "10.1371/journal.pone.0181780", "doi-asserted-by": "publisher", "key": "44" }, { "DOI": "10.1016/j.pharmthera.2020.107613", "doi-asserted-by": "publisher", "key": "45" }, { "DOI": "10.1385/bter:81:3:189", "doi-asserted-by": "publisher", "key": "46" }, { "DOI": "10.1016/j.nut.2020.111053", "doi-asserted-by": "publisher", "key": "47" }, { "DOI": "10.1159/000090495", "doi-asserted-by": "publisher", "key": "48" }, { "DOI": "10.1016/j.ijid.2020.09.014", "doi-asserted-by": "publisher", "key": "49" } ], "reference-count": 49, "references-count": 49, "relation": {}, "resource": { "primary": { "URL": "https://www.hindawi.com/journals/ecam/2021/8447545/" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Complementary and alternative medicine" ], "subtitle": [], "title": "A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActiveTM) for COVID-19 Patients", "type": "journal-article", "volume": "2021" }